expects the annual revenue potential for four drug
candidates to be launched within one and a half years to be at
least 10 billion Danish crowns ($1.78 billion), its chief
financial officer said.
Wednesday, 2 May 2012
Lundbeck sees blockbuster potenhtial in Treanda -CFO
COPENHAGEN, May 2 (Reuters) - Danish drugmaker Lundbeck
expects the annual revenue potential for four drug
candidates to be launched within one and a half years to be at
least 10 billion Danish crowns ($1.78 billion), its chief
financial officer said.
expects the annual revenue potential for four drug
candidates to be launched within one and a half years to be at
least 10 billion Danish crowns ($1.78 billion), its chief
financial officer said.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment